How do clinicians determine whether armodafinil is appropriate for excessive daytime sleepiness?

Armodafinil uses are generally limited to adults diagnosed with recognised sleep disorders such as narcolepsy, obstructive sleep apnea (OSA) with residual excessive daytime sleepiness despite primary therapy, and shift work sleep disorder (SWSD). Before recommending treatment, I first review the patient's sleep history, medical conditions, current medications, cardiovascular health, and occupational schedule to confirm that excessive daytime sleepiness is related to an underlying sleep disorder rather than another medical cause. In my practice, Armodafinil uses should always be considered as part of a comprehensive treatment plan rather than a replacement for healthy sleep habits or treatment of the primary sleep disorder. Regular follow-up helps evaluate wakefulness, daytime functioning, and overall clinical response while allowing treatment to be adjusted when appropriate. Reference: armodafinil. com. au/ product/ artvigil-50-mg